DNM1 and glioma: Future studies are planned to further evaluate and confirm clathrin-mediated endocytosis of TM601 in glioma cells by inhibiting this pathway using specific siRNAs against clathrin heavy chain and vectors encoding dominant negative mutant forms of dynamin or Epsin.